Recruitment of dendritic cells is responsible for intestinal epithelial damage in the pathogenesis of necrotizing enterocolitis by Cronobacter sakazakii

Journal of Immunology

Volumn 186, Issue 12, 2011, Pages 7067-7079

  Emami, Claudia N ^a,b   Mittal, Rahul ^a   Wang, Larry ^a   Ford, Henri R ^a,b   Prasadarao, Nemani V ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; NEUTRALIZING ANTIBODY; NITRIC OXIDE SYNTHASE; OUTER MEMBRANE PROTEIN A; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL INTERACTION; CELL MATURATION; CONTROLLED STUDY; CRONOBACTER SAKAZAKII; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INFECTION SENSITIVITY; INTESTINE CELL; INTESTINE EPITHELIUM; MEMBRANE PERMEABILITY; MOUSE; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; CACO-2 CELLS; COCULTURE TECHNIQUES; DENDRITIC CELLS; ENTEROBACTER SAKAZAKII; ENTEROCOLITIS, NECROTIZING; HUMANS; INTESTINAL MUCOSA; MICE; NITRIC OXIDE SYNTHASE TYPE II; TRANSFORMING GROWTH FACTOR BETA;

EID: 79959559486     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100108     Document Type: Article

References (50)

1. Henry, M. C., and R. L. Moss. 2009. Necrotizing enterocolitis. Annu. Rev. Med. 60: 111-124.
2. Pellegrini, M., N. Lagrasta, C. Garcìa Garcìa, J. Campos Serna, E. Zicari, and G. Marzocca. 2002. Neonatal necrotizing enterocolitis: a focus on. Eur. Rev. Med. Pharmacol. Sci. 6: 19-25.
3. Henry, M. C., and R. L. Moss. 2008. Neonatal necrotizing enterocolitis. Semin. Pediatr. Surg. 17: 98-109.
4. Holman, R. C., B. J. Stoll, and A. T. Curns. 2006. Necrotizing enterocolitis hospitalization among neonates in the United States. Paediatr. Perinat. Epidemiol. 20: 498-506.
5. Rowe, M. I., K. K. Reblock, A. G. Kurkchubasche, and P. J. Healey. 1994. Necrotizing enterocolitis in the extremely low birth weight infant. J. Pediatr. Surg. 29: 987-990, discussion 990-991.
6. Guillet, R., B. J. Stoll, C. M. Cotten, M. Gantz, S. McDonald, W. K. Poole, D. L. Phelps; National Institute of Child Health and Human Development Neonatal Research Network. 2006. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 117: e137-e142.
7. Llanos, A. R., M. E. Moss, M. C. Pinzòn, T. Dye, R. A. Sinkin, and J.W. Kendig. 2002. Epidemiology of neonatal necrotising enterocolitis: a population-based study. Paediatr. Perinat. Epidemiol. 16: 342-349.
8. Lin, P. W., and B. J. Stoll. 2006. Necrotising enterocolitis. Lancet 368: 1271-1283.
9. Yost, C. C. 2005. Neonatal necrotizing enterocolitis: diagnosis, management, and pathogenesis. J. Infus. Nurs. 28: 130-134.
10. van Acker, J., F. de Smet, G. Muyldermans, A. Bougatef, A. Naessens, and S. Lauwers. 2001. Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula. J. Clin. Microbiol. 39: 293-297.
11. Chenu, J. W., and J. M. Cox. 2009. Cronobacter ('Enterobacter sakazakii'): current status and future prospects. Lett. Appl. Microbiol. 49: 153-159.
12. Lai, K. K. 2001. Enterobacter sakazakii infections among neonates, infants, children, and adults. Case reports and a review of the literature. Medicine (Baltimore) 80: 113-122.
13. Centers for Disease Control and Prevention (CDC). 2002. Enterobacter sakazakii infections associated with the use of powdered infant formula - Tennessee, 2001. MMWR Morb. Mortal. Wkly. Rep. 51: 297-300.
14. Healy, B., S. Cooney, S. O'Brien, C. Iversen, P. Whyte, J. Nally, J. J. Callanan, and S. Fanning. 2010. Cronobacter (Enterobacter sakazakii): an opportunistic foodborne pathogen. Foodborne Pathog. Dis. 7: 339-350.
15. Nazarowec-White, M., and J. M. Farber. 1997. Enterobacter sakazakii: a review. Int. J. Food Microbiol. 34: 103-113.
16. Caubilla-Barron, J., E. Hurrell, S. Townsend, P. Cheetham, C. Loc-Carrillo, O. Fayet, M. F. Prère, and S. J. Forsythe. 2007. Genotypic and phenotypic analysis of Enterobacter sakazakii strains from an outbreak resulting in fatalities in a neonatal intensive care unit in France. J. Clin. Microbiol. 45: 3979-3985.
17. Simmons, B. P., M. S. Gelfand, M. Haas, L. Metts, and J. Ferguson. 1989. Enterobacter sakazakii infections in neonates associated with intrinsic contamination of a powdered infant formula. Infect. Control Hosp. Epidemiol. 10: 398-401.
18. Hunter, C. J., V. K. Singamsetty, N. K. Chokshi, P. Boyle, V. Camerini, A. V. Grishin, J. S. Upperman, H. R. Ford, and N. V. Prasadarao. 2008. Enterobacter sakazakii enhances epithelial cell injury by inducing apoptosis in a rat model of necrotizing enterocolitis. J. Infect. Dis. 198: 586-593.
19. Hunter, C. J., M. Williams, M. Petrosyan, Y. Guner, R. Mittal, D. Mock, J. S. Upperman, H. R. Ford, and N. V. Prasadarao. 2009. Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakiiinduced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis. Infect. Immun. 77: 1031-1043.
20. Potoka, D. A., E. P. Nadler, J. S. Upperman, and H. R. Ford. 2002. Role of nitric oxide and peroxynitrite in gut barrier failure. World J. Surg. 26: 806-811.
21. Chen, K., M. Inoue, and A. Okada. 1996. Expression of inducible nitric oxide synthase mRNA in rat digestive tissues after endotoxin and its role in intestinal mucosal injury. Biochem. Biophys. Res. Commun. 224: 703-708.
22. Tepperman, B. L., J. F. Brown, and B. J. Whittle. 1993. Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am. J. Physiol. 265: G214-G218.
23. Rescigno, M. 2010. Intestinal dendritic cells. Adv. Immunol. 107: 109-138.
24. Westendorf, A. M., D. Fleissner, W. Hansen, and J. Buer. 2010. T cells, dendritic cells and epithelial cells in intestinal homeostasis. Int. J. Med. Microbiol. 300: 11-18.
25. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296.
26. Rossi, M., and J. W. Young. 2005. Human dendritic cells: potent antigenpresenting cells at the crossroads of innate and adaptive immunity. J. Immunol. 175: 1373-1381.
27. Ng, S. C., M. A. Kamm, A. J. Stagg, and S. C. Knight. 2010. Intestinal dendritic cells: their role in bacterial recognition, lymphocyte homing, and intestinal inflammation. Inflamm. Bowel Dis. 16: 1787-1807.
28. Bedoui, S., A. Kupz, O. L. Wijburg, A. K. Walduck, M. Rescigno, and R. A. Strugnell. 2010. Different bacterial pathogens, different strategies, yet the aim is the same: evasion of intestinal dendritic cell recognition. J. Immunol. 184: 2237-2242.
29. Bauer, S., T. Müller, and S. Hamm. 2009. Pattern recognition by Toll-like receptors. Adv. Exp. Med. Biol. 653: 15-34.
30. Mittal, R., S. Bulgheresi, C. Emami, and N. V. Prasadarao. 2009. Enterobacter sakazakii targets DC-SIGN to induce immunosuppressive responses in dendritic cells by modulating MAPKs. J. Immunol. 183: 6588-6599.
31. Mittal, R., Y. Wang, C. J. Hunter, I. Gonzalez-Gomez, and N. V. Prasadarao. 2009. Brain damage in newborn rat model of meningitis by Enterobacter sakazakii: a role for outer membrane protein A. Lab. Invest. 89: 263-277.
32. Rimoldi, M., M. Chieppa, V. Salucci, F. Avogadri, A. Sonzogni, G. M. Sampietro, A. Nespoli, G. Viale, P. Allavena, and M. Rescigno. 2005. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol. 6: 507-514.
33. Mittal, R., and N. V. Prasadarao. 2010. Nitric oxide/cGMP signalling induces Escherichia coli K1 receptor expression and modulates the permeability in human brain endothelial cell monolayers during invasion. Cell. Microbiol. 12: 67-83.
34. McCall, I. C., A. Betanzos, D. A. Weber, P. Nava, G. W. Miller, and C. A. Parkos. 2009. Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization. Toxicol. Appl. Pharmacol. 241: 61-70.
35. Walsh, M. F., D. R. Ampasala, J. Hatfield, R. Vander Heide, S. Suer, A. K. Rishi, and M. D. Basson. 2008. Transforming growth factor-beta stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms. Am. J. Pathol. 173: 385-399.
36. Kamizato, M., K. Nishida, K. Masuda, K. Takeo, Y. Yamamoto, T. Kawai, S. Teshima-Kondo, T. Tanahashi, and K. Rokutan. 2009. Interleukin 10 inhibits interferon gamma- and tumor necrosis factor alpha-stimulated activation of NADPH oxidase 1 in human colonic epithelial cells and the mouse colon. J. Gastroenterol. 44: 1172-1184.
37. Rescigno, M., M. Urbano, B. Valzasina, M. Francolini, G. Rotta, R. Bonasio, F. Granucci, J. P. Kraehenbuhl, and P. Ricciardi-Castagnoli. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2: 361-367.
38. Chokshi, N. K., Y. S. Guner, C. J. Hunter, J. S. Upperman, A. Grishin, and H. R. Ford. 2008. The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis. Semin. Perinatol. 32: 92-99.
39. Petrosyan, M., Y. S. Guner, M. Williams, A. Grishin, and H. R. Ford. 2009. Current concepts regarding the pathogenesis of necrotizing enterocolitis. Pediatr. Surg. Int. 25: 309-318.
40. Cetin, S., C. L. Leaphart, J. Li, I. Ischenko, M. Hayman, J. Upperman, R. Zamora, S. Watkins, H. R. Ford, J. Wang, and D. J. Hackam. 2007. Nitric oxide inhibits enterocyte migration through activation of RhoA-GTPase in a SHP-2-dependent manner. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1347-G1358.
41. Cetin, S., H. R. Ford, L. R. Sysko, C. Agarwal, J. Wang, M. D. Neal, C. Baty, G. Apodaca, and D. J. Hackam. 2004. Endotoxin inhibits intestinal epithelial restitution through activation of Rho-GTPase and increased focal adhesions. J. Biol. Chem. 279: 24592-24600.
42. Vodovotz, Y. 1997. Control of nitric oxide production by transforming growth factor-beta1: mechanistic insights and potential relevance to human disease. Nitric Oxide 1: 3-17. (Pubitemid 28078123)
43. Miyajima, A., J. Chen, I. Kirman, D. P. Poppas, J. R. Darracott Vaughan E, and D. Felsen. 2000. Interaction of nitric oxide and transforming growth factor-beta1 induced by angiotensin II and mechanical stretch in rat renal tubular epithelial cells. J. Urol. 164: 1729-1734.
44. Vodovotz, Y., J. J. Letterio, A. G. Geiser, L. Chesler, A. B. Roberts, and J. Sparrow. 1996. Control of nitric oxide production by endogenous TGF-beta1 and systemic nitric oxide in retinal pigment epithelial cells and peritoneal macrophages. J. Leukoc. Biol. 60: 261-270.
45. Pan, X., X. Wang, W. Lei, L. Min, Y. Yang, X. Wang, and J. Song. 2009. Nitric oxide suppresses transforming growth factor-beta1-induced epithelial-tomesenchymal transition and apoptosis in mouse hepatocytes. Hepatology 50: 1577-1587.
46. Maheshwari, A., D. R. Kelly, T. Nicola, N. Ambalavanan, S. K. Jain, J. Murphy-Ullrich, M. Athar, M. Shimamura, V. Bhandari, C. Aprahamian, et al. 2011. TGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology 140: 242-253.
47. Leaphart, C. L., J. Cavallo, S. C. Gribar, S. Cetin, J. Li, M. F. Branca, T. D. Dubowski, C. P. Sodhi, and D. J. Hackam. 2007. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J. Immunol. 179: 4808-4820.
48. Cascales, E. 2008. The type VI secretion toolkit. EMBO Rep. 9: 735-741.
49. Suarez, G., J. C. Sierra, T. E. Erova, J. Sha, A. J. Horneman, and A. K. Chopra. 2010. A type VI secretion system effector protein, VgrG1, from Aeromonas hydrophila that induces host cell toxicity by ADP ribosylation of actin. J. Bacteriol. 192: 155-168.
50. Pukatzki, S., S. B. McAuley, and S. T. Miyata. 2009. The type VI secretion system: translocation of effectors and effector-domains. Curr. Opin. Microbiol. 12: 11-17.